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According to the National Institutes of Health’s Osteoporosis and Related Bone 
Diseases Resource Center, approximately ten million people are affected by osteoporosis 
each year.  Twenty percent of these are men (1).  Comprehension of osteoporosis among 
men is limited.  Within a sample of elderly men, most interviewees recognized the term 
osteoporosis, yet only about 44% of the men were able to correctly define it (2).  This 
condition of porous bone is distinguished by a loss of bone mass, structure, and strength.  
Prevention of osteoporosis focuses on increasing peak bone mass at an early age and 
maintaining bone mass later in life.  Treatments may include lifestyle modifications, 
including changing dietary habits, and pharmaceutical therapy (3).  
Bone is a living tissue that continually experiences transformation.  Continued 
degradation of bone without adequate tissue repair implies a risk for fracture, the most
debilitating complication of osteoporosis.  In elderly or medically unstable populations, 
full recovery from fracture is rare.  In populations who develop osteoporosis, perceptions 
of high stress, low self-concept, high psychological distress and other psychosocial 
factors influence the ability of men and women to perform activities of daily living (4).  
In addition to painful symptoms, osteoporosis-related fractures contribute to a lower 
survival rate.  For men, the reduction in life expectancy due to osteoporosis outweighs the 
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reduction in life expectancy for women (5).  Goals for treating osteoporosis and 
improving bone health ultimately include reducing the occurrence and severity of 
fractures.   
Osteoporosis is diagnosed clinically using dual-energy X-ray absorptiometry 
(DXA) to estimate bone mineral density (BMD).  In women, a T-score that is less than 
2.5 standard deviations (SD) below the mean of a young adult qualifies as a diagnosis of 
osteoporosis.  Due to the relatively few studies of male osteoporosis, diagnostic standards 
are less clearly defined.  Treatment may be indicated if a male patient is over the age of 
70, has a BMD less than 2.5 SD below the mean, or has a history of long-term 
corticosteroid use with a BMD lower than 1.5 SD (6).  However, due to the complexity of 
bone, an assessment based solely on DXA measurements of BMD may be inadequate for 
determining bone health.  Assessments of the microarchitecture, structure, strength, and 
material properties of bone provide a more in-depth analysis of bone quality and fracture 
risk but may not be feasible in humans (7). 
While certain risk factors can not be modified, i.e. race, age, and family history of 
osteoporosis, others are quite pliable.  Lifestyle factors affected by behaviors may include 
adequate calcium and vitamin D intakes, an appropriate body mass index (BMI), 
medications, and nutrition-supported hormone replacement therapy and weight-bearing 
exercise (8).  A complete and balanced intake of macronutrients, micronutrients, and 
other bioactive food components provides for optimal bone health.  Without an adequate 
diet, treatment success is limited.   
The aim of this thesis is to investigate the role of orange pulp in bone health.  The 
etiology and pathophysiology of osteoporosis, specifically male osteoporosis, will be 
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briefly discussed.  Potential mechanisms of action for nutrients and bioactive compounds 
in citrus will also be briefly reviewed.  Clinical implications of these food components 
are relevant considering the possibility for prevention of morbidity and mortality 
associated with male osteoporosis.  
Research Objective 
 The objective of this study was to evaluate effects of enhancing citrus intake on 
bone quality in a rat model of male osteoporosis (orchidectomized one-year-old retired-
breeder Sprague-Dawley rats).  The specific aim of the experiment was to determine if 
feeding orange pulp to orchidectomized rats dose-dependently reduces bone resorption as 
assessed by measurements of bone density, structure, and strength in fourth lumbar 
vertebra and left proximal tibias. 
Hypothesis 
 Literature suggests an interaction between antioxidants and bone remodeling.  
Therefore, we hypothesize that feeding orange pulp to year-old orchidectomized rats will 
dose-dependently improve bone structure and strength.   
Limitations 
 There are certain limitations in using an animal model of aging male osteoporosis 
to study a disease seen in the human male population.  For example, although rats have 
similar growth periods, they are not identical in relation to their respective life spans.  
Total blood and tissue availability for analysis is reduced due to smaller body size in rats.  
Physiologically, the Haversian remodeling system is minimized in rats, thus limiting 
ability to estimate cortical remodeling.  Sudden depletion of hormones via orchidectomy 
may have more dramatic effects on bone compared to the gradual reduction of hormones 
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seen in aging.  The findings of this study hence cannot be extrapolated directly to humans 
due to species-specific differences between rats and humans.     
Format of Thesis 
The PubMed database and Reference Manager software were utilized as primary 
search tools to locate pertinent research articles and reviews.  Search terms and major 
themes highlighted in this review include the following:  bone, biology, osteoporosis, 
androgens, antioxidants, flavonoids, hesperitin, naringenin, orange, DXA, orchidectomy, 
micro-computed tomography (μCT), and finite element (FE) analysis.  Retrieved article 
reference lists were also reviewed to identify additional citations.   
The thesis was organized based on the Oklahoma State University thesis 
guidelines.  Chapter IV is formatted as a manuscript for submission to Journal of 







REVIEW OF LITERATURE 
Ageing Male Osteoporosis 
The dynamic process of ageing often results in a decline of function.  In men and 
women alike, age is related to an increased rate of fractures.  There is an increased rate of 
bone resorption in elderly populations, and the processes of bone resorption and bone 
formation are no longer balanced (9, 10).  Biomarker indices of bone formation are 
inconsistent among elderly individuals.  Elevation in some markers (i.e. serum 
osteocalcin, bone-specific alkaline phosphatase, procollagen peptides) may indicate an 
increase in bone turnover, not necessarily bone formation (11, 12). 
Multiple factors contribute to the likelihood of fractures with ageing.  In addition 
to an average loss of muscle and tissue strength, nutritional deficiencies, hormonal 
changes, environmental and genetic influences exacerbate tendencies to experience 
fractures.  Loss of ability to balance properly and lack of shock absorption qualities 
associated with impact surfaces contribute to falling incidents with resulting injury (13).  
Compared to the force a bone can withstand prior to tissue fatigue from impact, the force 
of expected impact must be close to or greater than one before fracture is likely.  In the 
elderly, a ratio of 0.3 exists when merely standing.  When climbing stairs, the ratio 
approaches 0.6.  Ratios resulting from falls can range from one to over 70.  
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Illnesses are common in elderly individuals and often result in medication usage, fatigue, 
and loss of equilibrium associated with falls (14).       
Osteoporosis is not a sex-specific disease.  Although typically recognized as a 
condition affecting women, osteoporosis affects men as well.  Males who experience 
severely low gonadal function over time are at increased risk for developing osteoporosis.  
Deterioration of trabecular bone mass is associated with low testosterone levels in males 
(15).  Mortality rates in men post hip fractures are twice as high as rates in women (16, 
17).  In men whose fractures result in hospitalization, almost one in ten dies (8% 
mortality rate), while only about one in 30 women die during hospitalization due to 
fracture (18).   
As men age, a sharp decline in bone formation compared to bone resorption 
occurs, although approximately five to ten years later than that of women.  Men typically 
experience secondary osteoporosis based on conditions resulting from medical 
complications.  In addition to hypogonadism, alcohol abuse and excessive use of 
glucocorticoids increase risk of fractures.  Only one-third to one-half of males with 
osteoporosis experience primary osteoporosis (related to aging or idiopathic) (19, 20).  
Men have a decreased risk of fracture compared with women.  This advantage is 
related to a greater accumulation of bone mass, including increased periosteal bone 
formation and expansion, as well as a delayed onset of loss of bone mass (21).  Bone 
development in adolescent males attains a higher peak mass than that of females.  
Furthermore, thicker cortices and larger bones are usually associated with the male 
gender.  Other risk factors typically associated with the female gender include low body 
weight, decreased physical activity, and menopausal decrease in estrogen.   
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Hormones and Bone Metabolism 
Growth factors, cytokines, and systemic hormones exert influence over the 
balance of bone resorption and formation through positive and negative feedback loops 
and proliferation and activation of osteoblasts and/or osteoclasts and their subsequent 
local mediators (22).  Both androgen-receptors and estrogen-receptors are contained 
within bone cells (23). 
Hormone levels also vary according to age.  Estrogen is a primary hormone in 
maintaining bone mineral density (BMD) and acts as a stimulant of osteoprotegerin 
(OPG).  Estrogen levels correlated strongly with elderly male BMD in a Framingham 
cohort (24).  Reduction of osteoclastogenesis is enhanced by estrogen inhibition of 
Interleukin-1 (IL-1), Interleukin-6 (IL-6), Macrophage-Colony Stimulating Factor (M-
CSF), Tumor Necrosis Factor-alpha (TNF-α), and prostaglandin E2 (PGE2) (25).   
Estrogen is associated with higher bone mass.  Insufficient estrogen results in 
greater secretion of cytokines and RANK ligand.  Cytokines act to recruit and stimulate 
osteoclasts.  IL-1, IL-6, TNF-α, and M-CSF are released at an increased rate from 
monocytes, marrow stromal cells and granulocytes resulting in increased resorptive 
activity when estrogen is low (26).  Trabecular skeletal bone has greater surface area than 
cortical bone and is most affected by estrogen deficiency (27). 
Androgens may also impact bone mass through promoting formation of bone, 
while estrogen seems to be more involved in preventing bone loss.  Hormone levels and 
gonadal function are affected by the aging process.  Testosterone levels in the serum are 
reduced in aging by about 1.2% per year.  Furthermore, sex-hormone binding globulin 
(SHBG) levels rise with age (28).   
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Benito et al. studied testosterone replacement in hypogonadal men to determine 
effects on trabecular microarchitecture.  Ten subjects were recruited based on below 
normal levels of testosterone documented on two occasions (mean 88 ± 51 ng/d [3.1 ± 
1.8 nM]) resulting from known pituitary or hypothalamic disease.  Eugonadal test 
volunteers were paired for race and age ± ten years to each hypogonadal man.  
Transdermal testosterone gel was self-administered daily beginning with a dose of 50 mg 
per day and increased to as much as 100 mg per day.  Serum testosterone increased 
notably from subnormal levels to midnormal levels (656 ± 332 ng/dl [22.8 ± 11.5nM]) by 
the third month of treatment. Within hypogonadal men pre- and post- 24 month 
testosterone treatment, comparisons of anterior-posterior (L1-L4) and right hip DXA 
scans revealed significantly improved spine (p <0.001), total hip (p =0.008), trochanter (p 
= 0.04), and interchanteric BMD (p =0.004).  μMRI assessment of the right distal tibia in 
these hypogonadal men revealed significantly improved architectural parameters, 
including bone volume fraction (p <0.001), trabecular thickness (p <0.001), surface-to-
curve ratio (p =0.004), and topological erosion index (p =0.004) following the 24 month 
treatment period.  Improved surface-to-curve ratio and topological erosion index 
measures indicate restoration of trabecular connectivity and reversal of deterioration of 
trabecular architecture due to low testosterone levels (29).  
Over a period of ten years, growth hormone (GH) levels are decreased by about 
14% (30).  In older men and women, this decrease in GH subsequently reduces insulin-
like growth factor concentrations.  Adrenal androgen (dehydroepiandrosterone, DHEA; 
dehydroepiandrosterone sulfate, DHEA-S) levels are also known to decline with age (31). 
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The Orchidectomized Rat Model of Ageing Male Osteoporosis 
Men are at an increased risk for osteoporosis as aging occurs.  Due to 
complications and difficulty in maintaining homogenous experimental conditions for 
human volunteers, it is useful to choose an appropriate animal model to approximate 
biological effects of treatment.  Rats have similar growth phases to humans and offer a 
convenient model with fewer ethical constraints versus humans and other nonprimate 
animal models.  According to the ACE Animals Inc. website Sprague Dawley rats have a 
lifespan of 2.5-3.5 years (32).  Thus, a one-year-old rat is middle aged and nearly 
beginning to enter the second half of life by the end of a four month study.  This age 
allows time for bone analysis without complications from ageing male osteoporosis in the 
rats.  Sprague-Dawley rats appear to be a consistent model for analyzing age-related bone 
loss in trabecular and cortical bone (33).  Remodeling of trabecular bone is quite similar 
in activation, formation, and resorption mechanisms (34). 
Bone Development, Skeletal Homeostasis, Bone Metabolism 
The skeletal system includes bone and cartilaginous tissue.  Bone is composed of 
protein fibers, primarily collagen type I proteins that are arranged in a lamellar structure.  
Glycoproteins and proteoglycans aid in attaching hydroxyapatite crystals to the collagen 
matrix.  Functionally, bone is a specific type of connective tissue that provides protection 
for vital organs, supports movement, and operates as a reservoir for minerals in order to 
maintain homeostasis.  Osteoblasts, osteoclasts, bone lining cells, and osteocytes are the 
four types of bone cells.  Osteocytes are found inside the bone, while the other cell types 
are located on the bone surface.  Trabecular bone is known as spongy or cancellous bone, 
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while cortical bone forms the outer compact bone.  The extracellular matrix is composed 
of organic and inorganic substances (35, 36).   
Bone formation involves manipulation of inorganic and organic layers and 
interaction between multiple biological, environmental, and genetic influences.  The role 
of osteoblasts is to build bone; they synthesize the organic matrix of proteins and 
polysaccharides.  Bone turnover involves the formation of bone by osteoblasts and the 
resorption of bone by osteoclasts.  Both cell types are affected by numerous activating 
and inhibiting factors.  Osteoblasts build bone as cells mature and become fixed and 
calcified within the protein matrix.  As this process continues, osteoblasts become known 
as osteocytes or flat lining cells.   
Bone Formation 
Osteoblast presence and activity within the bone regulates bone formation.  
Osteoblasts and bone protective factors are stimulated by a variety of endogenous and 
environmental factors (37).  Adequate nutrition, weight-bearing exercise, and controlled 
hormone levels are important in promoting bone health (38).  Osteoblasts originate from 
undifferentiated mesenchymal cells from the marrow, endosteum, periosteum, and bone 
canals (39).  Complex signaling pathways function to modulate osteoblastogenesis and 
subsequent bone forming capabilities (37).   
The collagen matrix is further constructed outside the osteoblast following its 
synthesis.  It is primarily composed of type I collagen, although types V, VI, VIII, and 
XII are also involved.  Fibrils of collagen overlap in a particular manner that leaves space 
between fibrils and forms the porous foundation linked with intermolecular structures to 
provide a functional framework and strength.  Bone mineralization begins at a rapid rate 
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and greater than half of localized mineralization is complete within a few hours.  
However, final completion proceeds at a gradual rate.  Apatite and calcium-phosphate 
crystals deposit within and between collagen fibrils.  As mineralization progresses, the 
bone becomes more hard and dense if appropriately supported (39). 
This reservoir of minerals aids the body in achieving and monitoring mineral 
homeostasis.  Bone serves as the primary source of the body’s mineral salts, comprising 
approximately 99% of the calcium, 85% of the phosphorus, and about half of the sodium 
and magnesium found in the average individual (39).  
Bone Remodeling 
Bone remodeling requires a coupling of osteoclast cells with osteoblast cells.  
Initially, osteoclasts are stimulated by osteoblast precursors.  Osteoclast cells function to 
break down bone, while osteoblast cells form new bone.  Ideally, bone formation 
proceeds at a rate balanced with resorption processes.  Remodeling is constantly utilizing 
a variety of factors which function to maintain skeletal homeostasis (25).   
During the growth period, the epiphyseal cartilage region of the bone elongates 
prior to age-related ossification.  Calcification of the epiphyseal cartilage into bone 
results in cessation of elongating growth.  Remodeling, however, continues throughout 
the life cycle.  The external cortex of bone, also known as compact bone, surrounds the 
inner marrow responsible for hematopoiesis.  Near the ends of the bone, epiphysis and 
metaphysis, internal networks of calcified matrices are formed as trabecular bone 
(cancellous or spongy).  Trabeculae are more conducive to metabolic functions, as 
opposed to protection and mechanical utility provided by the cortical bone (34).   
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Sex steroids, i.e. estrogen and androgens, affect bone development and 
maintenance in both males and females (40).  Estrogen reduces osteoclast action through 
inhibiting the production of membrane bound M-CSF, receptor activator of NFκB ligand 
(RANKL), IL-1, IL-6, and TNF-α and initiating synthesis of osteoprotegerin (OPG), and 
transforming growth factor (TGF-β) (40).   
M-CSF is involved in the differentiation and proliferation of preosteoclast cells 
through expression of receptor activator of NFκB (RANK).  The interaction of RANK 
and RANKL induces the differentiation and activity of osteoclasts.   
 Osteoclasts produce superoxide dismutase and other reactive oxygen species 
(ROS) which in turn speed bone demineralization and remodeling (41).  Some ROS act to 
stimulate osteoclastogenesis.  Previous research documents the strong positive relation 
between oxidative stress and bone loss (41).  Sixty days post ovariectomy (OVX), three 
month old female Wistar rats were killed and their antioxidant enzyme levels from 
homogenized femora samples were compared to controls.  Hydrogen peroxide and lipid 
peroxidation, as indicators of stress, were significantly elevated in OVX rats.  
Glutathione S- transferase, superoxide dismutase and glutathione peroxidase levels were 
significantly reduced in OVX, suggesting an impairment in bone antioxidant enzyme 
activity (42).   
In sex-steroid deficient mice, antioxidant levels in bone are lowered.  This 
reduction results in an increase in ROS-mediated reactions, bone degradation, and 
resorption factors.  TNF-α expression is stimulated and consequently increases bone loss 
(43). Interleukins 1, 6, 11, 15, and 17, in addition to TNF-α, Parathyroid Hormone (PTH), 
and 1, 25-OH vitamin D3, excite cytokines which alter osteoclast activity (25). Upon 
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initial binding of RANKL to RANK, the TNF receptor activating factor (TRAF) family is 
stimulated resulting in key pairing of critical signals that serve to regulate osteoclast 
synthesis and action (25).  Additional factors such as prostaglandins, calcitriol, 
lipopolysaccharide, glucocorticoids, histamine, lack of weight-bearing activity, and 
genetic expression are important in osteoclastogenesis and activation (37).  
In contrast, other factors are critical to suppression of osteoclast formation and 
activation.  OPG inhibits osteoclast differentiation (25).  Transforming growth factor-B 
(TGF-B), interferon-γ, calcitonin and interleukins 4, 10, 12, 13, and 18 also inhibit 
osteoclasts through increasing OPG synthesis and reducing expression of RANKL (25, 
44).   
Hormone Deficiency and Osteoporosis 
Excessive bone resorption, inadequate bone formation, and a failure to reach peak 
bone mass during growth and development increase the likelihood of experiencing 
osteoporosis.  Osteoporosis in men has become a more significant threat to health as life-
span has increased.  Similar to a postmenopausal lack of estrogen, androgen loss has a 
negative effect on bone maintenance.  Compared to sham-operated Fisher 344 rats 13 
months of age, orchidectomized (ORX) equivalents experienced a 7% loss of bone 
mineral density (BMD) over 180 days (45). 
Male hormone deficiency appears to act similarly to female hormone deficiency, 
although at a slower pace.  Male Wistar rats were evaluated at six months of age, 90 days 
following castration.  Animals were killed and left mandibles evaluated to assess 
differences in periodontal ligament and alveolar bone thickness compared to non-
castrated controls.  While periodontal ligament fibers appeared disorganized and the 
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alveolar bone had increased numbers of osteoclasts compared to controls, these trends 
were not significant.  This morphometric analysis suggests that males experience bone 
loss at a less rapid rate, although characteristic changes associated with hormone loss 
were evident (46).   
Androgens, such as testosterone, dihydrotestosterone, and 
dehydroepiandrosterone, can have a direct effect through bone cell receptors or an 
indirect effect through conversion to estrogens through aromatization.  Osteoblast cells 
are particularly sensitive to androgens and respond through increasing cell proliferation, 
cell differentiation, protein production, and mineralization (47). 
Orchidectomy contributes to low plasma levels of estradiol (estrogens) (48, 49).  
The terminal enzyme necessary for irreversible conversion of androgens into estrogens is 
the cytochrome P450 aromatase (50).  Deficiency of this enzyme in case reports of four 
young men have consistently shown elevated bone remodeling markers with critically 
osteopenic skeletal phenotypes.   Administration of testosterone did not restore bone 
health, while estrogen improved bone mass (51-54).   
In elderly males, testosterone levels decline.  The ratio of free plasma testosterone 
concentration to free plasma estradiol concentration also declines, suggesting that 
aromatase activity is increased in elderly males.  This allows for plasma estradiol levels 
in males (2-3 ng/dl) to exceed those of postmenopausal women (2.01 pmol/L, (55)), 
partially explaining bone retention in males compared to females.  Estradiol has a 
protective effect on bone and is vital in regulating skeletal homeostasis in males as well 
as females (56).  Fracture status was inversely associated with total (64.1 vs 75.4 pmol/L, 
p=0.012) and bioavailable (43.0 vs 51.4 pmol/L, p=0.008) estradiol levels in men (57). 
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Nutrition and Bone Health 
Dietary Guidelines for Americans, 2005, recommends a selection of balanced and 
varied foods, including a high intake of nutrient dense fruits and vegetables (58).  
Vitamins and minerals are important in maintaining optimal skeletal health.  Adequate 
levels of intake of calcium, vitamin A, vitamin C, vitamin D, vitamin K, potassium, iron, 
magnesium, and molybdenum have been implicated as beneficial in some aspects of bone 
health.  Elderly populations are at a higher risk for inadequacy of many nutrients (59). 
A diet high in fruits and vegetables is associated with increased bone mineral 
density.  Effects of onions and other vegetables have been examined by Muhlbauer et al.  
Bone loss in seven week old male rats labeled with [3H]-Tetracycline, was evaluated 
following a four week administration of onions and 13 other vegetables.  Varied 
vegetables accrued an additive prevention of bone resorption, with onions being most 
potent.  An ovariectomized (OVX) model was also used to assess dose-dependent effects 
of feeding graded doses of onion to female rats for 10 days post surgery.  One and a half 
grams of onion inhibited bone resorption at a similar level (26±4% vs. 24±3%, 
respectively) to that of 17β-estradiol (27μg/kg body weight) (60). Recent research 
indicates that positive bone effects are not due to excess base (increased pH) related to 
concentrations of potassium, but rather to a bioactive compound.  Despite being added to 
a vegetarian diet, onion maintains its ability to inhibit bone resorptive activity.  
Furthermore, buffering of metabolic acid by adding potassium citrate failed to inhibit 
bone resorption. This further supports an independent mechanism (61).   
Fruits also provide important nutrients for bone health.  Males between the ages 
of 31-50 years would need an estimated 150% increase in consumption above current 
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fruit intakes, or an actual increase of about 1.2 cups daily, to meet recommendations of 
the Dietary Guidelines 2005 for fruit intake (62).  As an alternative to pharmaceutical 
management of osteoporosis, previous studies have demonstrated the effectiveness of 
functional foods, including fruit, in bone health.   
Arjmandi et al. reported daily consumption of 100 g dried plums was effective in 
increasing mean serum levels of insulin-like growth factor-I and bone-specific alkaline 
phosphatase activity in a sample 58 postmenopausal women over a three month period, 
indicating higher rates of bone formation without affecting bone resorption markers.  
Seventy-five grams of dried apples comparatively provided similar amount of calories, 
fat, carbohydrate, and fiber per day (63).  
In a later study, Deyhim et al. reported dried plum’s (Prunus domestica L.) 
efficacy in restoring bone loss in 90 day old ovariectomized (OVX) Sprague-Dawley rats 
over a two month period.  Rats were fed standard diets for 40 days to allow for bone loss 
effects to be seen post surgery prior to beginning experimental diets.  Experimental 
groups included SHAM (sham-operated), OVX_0%, OVX_17β-estradiol (10 μg/kg body 
weight), OVX_5% dried plum, OVX_15% dried plum, OVX_25% dried plum.  Groups 
received standard diet plus respective treatments.  In all dried plum groups, femoral and 
tibial bone density was restored.  OVX_25% dried plum also increased lumbar bone 
density significantly.  Interestingly, dried plum fed in varying amounts improved 
trabecular microarchitectural properties, including bone volume and connectivity, in 
comparison with OVX after bone loss occurred (64).  
Another functional food component, soy, has shown both antiestrogenic and 
estrogenic qualities.  In a study of nine month old ovariectomized (OVX) rats, 7% added 
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dietary soy increased bone formation and bone density in some bones over a nine week 
period (65).  Genistein, a main bioactive compound present in soy, increased BMD only.  
No other estrogen agonistic effects were seen.  Results showed inhibited uterine weight 
and increased frequency of B lymphopoietic bone marrow cells, which are antiestrogenic 
effects (66). 
Antioxidants and Bone  
Free radical damage at the cellular level and subsequent signaling pathway 
activation has been indicated in the process of senescence.  Reactive oxygen species 
(ROS), (i.e. hydrogen peroxide, superoxide anions, and hydroxyl radicals), continuously 
impact vital biological components.  Proteins, lipids, and DNA can be damaged by ROS 
with serious consequences (67).  In a study of 48 women and 53 men, the association 
between in vivo oxidative stress biomarker 8-iso-PGF and bone mineral density was 
examined.  Urinary samples of isoprostane 8-iso-PGF indicated a negative relation to 
BMD.  Higher levels were correlated with lower BMD of total body (p < 0.001) and 
lumbar spine (p < 0.04) (68).   
Animal studies have shown a relation between oxidative stress and bone 
resorption.  Free radicals are related to osteoclastogenesis.  Bone resorption is affected by 
nuclear factor-κB (NF-κB).  NF-κB is a vital transcription factor in osteoclastogenesis.  
Activation of NF-κB can occur during oxidative stress in a cell-specific way (67).  In 
mice lacking NF-κB1 and NF-κB2 gene expression proteins, osteopetrosis unexpectedly 
occurred. This implicates the importance of NF-κB in osteoclastogenesis and 
differentiation (69).  Altered bone resorption may be related to imbalances in oxidative 
activation of NF-κB.  DXA analyses of 31 male patients with primary osteoporosis, 
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yielded a significant negative correlation between lumbar and femoral neck BMD 
evaluation and superoxide dismutase activity and nitric oxide levels (70).   
Orange Pulp Components and Their Effects 
 Citrus antioxidant studies appear to confirm the role of an overall health-
conscious diet meeting the USDA Dietary Guidelines as important for bone health (71).  
Due to benefits from multiple assorted foods, it is important to honor balance and variety 
in the diet.   
Orange production in the United States (US) is assessed at 8.4 million tons for 
2005/06.  Adjusted for weight of inconsumable waste, from 1970 to 2004 per capita 
consumption of fresh oranges has decreased from an average of 7.3 pounds per year (9.1 
g per day) to 4.9 pounds per year (6.1 g per day).  Juice consumption remained 
approximately the same from 3.2 gallons per year (32 g per day) in 1970 to 3.2 gallons 
per year (31.6 g per day) (72).  The majority of Florida oranges are processed for juice, 
contributing to the overall 68% of total citrus crop expected to be utilized for juice this 
year.  Exported oranges totaled 550,000 oranges for 2005/06 (73).   
Citrus fruits contain many flavonoids in addition to important nutrients such as 
vitamin C and potassium.  Vitamin C, or ascorbic acid, levels correlate with total 
antioxidant capacity (74).  Well-known antioxidant capacity of vitamin C suggests 
promotion of bone formation and reduction of resorption.  Ascorbic acid is important in 
the prevention of scurvy and in collagen maintenance and formation.  Collagen forms the 
backbone matrix for bone mineralization.  Ascorbic acid has been shown to induce the 
formation of osteoblasts from embryonic stem cells.  In vitro stimulation of pre-
osteoblast gene mouse-calvaria derived cell lines provides evidence of ascorbic acid 
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promotion of bone formation through promotion of osteoblast differention (75).  Phenolic 
antioxidant compounds present in orange juice, primarily hesperidin and narirutin, spare 
vitamin C from oxidation, thus enhancing total antioxidant capacity (76).  
DXA assessments suggested an association between dietary fruit and vitamin C 
intakes in adolescent boys in spine size-adjusted bone mineral content (77). Alternate 
studies indicate alkaline-producing dietary components such as fruits, vegetables, 
magnesium, and potassium appear to be associated with increased BMD.  Furthermore, 
magnesium and potassium intakes were significantly associated with higher bone mineral 
density in hip and forearm assessments (p < 0.05) (78).   
Bioactive Components of Orange Pulp:  Citrus Bioflavonoids and Limonoids  
Flavonoids and limonoids are primary classes of bioactive components in citrus 
fruits.  Substances isolated from Citrus sinensis (C. sinensis) included nobiletin, 
sinensetin, tetramethylscutellarein, heptamethoxyflavone, tangeretin, 3,5,6,7,3 ,4 -
hexamethoxyflavone, 5-Hydroxy-6,7,3 ,4 -tetramethoxyflavone, and 3,5,7,8,3 ,4 -
hexamethoxyflavone, listed in order of declining concentrations.  Hesperidin and ferulic 
acid were also isolated from the orange peel.  Following isolation, components were 
evaluated for capability to inhibit 15-lipoxygenase.  Radical scavenging capabilities were 
also assessed using diphenylpicrylhydrazyl radical.  Researchers found that their ability 
to inhibit catalyzation of lipid peroxidation in vivo was more notable than ability to 
scavenge radicals (79). 
Flavonoids are polyphenolic and differentiated by a C6-C3-C6 carbon backbone 
of the low-molecular weight parent flavone compound (2-phenyl chromone or 2 –phenyl 
benzopyrone).  Hydrophilic character and number of hydroxyl groups are important 
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factors in protecting membrane integrity through flavonoid interaction.  Researchers 
found hydrophilic flavonoids prevent lipid oxidation, modulate membrane fluidity, and 
protect membranes from disruption by detergent.  Chemically flavonoids offer a structure 
useful for quenching free radicals due to the 3’-4’ hydroxyl groups and the 2,3 double 
bond conjugated to a 4-ozo group in the C ring and hydroxyl groups in the 3 and 5 
positions.  Polar characteristics of membrane head groups increase ability of hydrophilic 
flavonoids to interact with membranes possibly due to hydrogen bonding.  Affinity for 
liposomes was correlated with number of hydroxyl groups.  The flavonones naringenin 
and hesperitin are more tilted in configuration compared to flavonols with less potential 
for membrane surface interaction (80).  The differences in flavonoids, flavonones, and 
flavonols are shown in the following figure copied from Erlejman, 2004, (80): 
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Antioxidant capacity varies with structure and the existence of adjacent hydroxy 
groups within the structure.  Based on experimentation with free-radical scavenging 
system 1, 1-diphenyl-2-picrylhydrazyl and the methyl linoleate oxidation system, 
fermentation produced hydroxyflavone forms (8-hydroxyhesperitin, 6-
hydroxynaringenin, and 8-hydroxynaringenin) are more potent free-radical scavengers 
with greater antioxidant activity than the aglycones hesperitin and naringenin.  Aglycone 
derivatives are, however, more successful antioxidants than flavonone glycosides 
hesperidin and naringin (81). 
Flavonoids:  Hesperidin and Naringin 
Due to their phenolic properties, flavonoids interact uniquely within membranes 
and offer protection from the harmful effects of lipid peroxidation and free radicals (82).  
The citrus flavonoid hesperidin inhibits bone loss through reduction of osteoclast number 
and through improved mineralization of calcium, phosphorus, and zinc (83).  Naringin, 
another citrus flavonoid, increases bone formation when bone grafts are incorporated 
with naringin in collagen matrix (84).  Both hesperidin and naringin inhibit the activity of 
3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, similar to the action of a statin 
drug (83, 84).   
Endocrine effects of narigenin and hesperitin may partially account for benefits to 
bone health.  Even in men, estrogen is important for maintaining bone and preventing 
resorption (57).  Naringenin, in contrast to glucoside derivative naringin, was identified 
as a ligand for sex-hormone binding globulin (SHBG).  Xenoestrogens, such as 
naringenin and genistein, act as ligands to increase free plasma levels of endogenous 
testosterone and estradiol through displacement from human plasma SHBG (85).   
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Hesperidin 
An early clinical study in 94 women found that hesperidin aided in reducing 
menopausal symptoms and in the regulation of oestrogen (86).  In a recent study, Chiba 
et al. ovariectomized (OVX) female mice to induce bone loss.  Mice were fed 5 g/kg 
body weight hesperidin, 7 g/kg body weight α-glucosylhesperidin, or administered 0.3 
μg/day 17β-estradiol.  In OVX mice, proximal, middle, and distal femur regions showed 
significant bone loss.  This loss was corrected and calcium, phosphorus and zinc 
concentrations were higher in all treatment groups other than OVX.  In 
histomorphometric evaluation, trabecular bone volume fraction, thickness and separation 
were negatively impacted in the femoral metaphysis of OVX mice.  In mice fed α-
glucosylhesperidin, trabecular separation was significantly improved compared to OVX, 
but not restored to the level of SHAM.  Estradiol treatment prevented all OVX-induced 
changes.  Both forms of hesperidin treatments reduced osteoclast number.  While 
estrogen-receptor (ER) effects could be possible, it seems unlikely in lieu of the methoxy 
group in the 4’ B ring flavan nucleus of hesperidin.  In order to gain estrogen potency, 
Chiba et al. hypothesize that a single hydroxyl group is required (83). 
Estrogen elimination is inhibited by flavonones hesperitin and naringenin.  In rat 
liver microsomes hesperitin and naringenin strongly inhibit glucuronidase, an enzyme 
that aids in glucuronidation and subsequent elimination of estrogen (IC50 value at 25 
μM).  Inhibition of glucuronidase reduces liver metabolism and elimination of estrogen.  
At 10μM and 50 μM, flavonones have competitive and noncompetitive inhibition 




These structures of naringenin and hesperitin are adapted from Ameer, 1996, (88). 
Naringin and Naringenin  
As a phytoestrogen, relatively low concentrations of naringenin succeeded in 
displacing testosterone and estradiol from SHBG, whereas high concentrations of 
naringin were required.  The amount of substance (mmol.1-1) needed to displace 50% of 
estradiol from SHBG was 1.9 for naringenin versus 0.0031 for estradiol and 4.25 for 
genistein.  The concentration (nmol.1-1) needed to displace 50% of testosterone was 1.69 
for naringenin versus 1.25 for genistin (85).  Northern analysis of cells treated with 10 
mmol naringenin revealed increased activity of the activator function 2 (AF2) of estrogen 
receptors.  This tendency to act as an estrogen agonist was equipotent with endosulfan 
isomers, yet less potent than genistein and coumestrol in myometrial rat cells in 





Previously, significant dietary flavonol absorption was doubted.  Due to β-
glycosidic bonds, it was presumed that gut absorption of bound flavonoids would be 
minimal.  However, a study in ileostomy patients provided evidence for greater 
absorption of bound quercetin flavonoid versus both aglycone quercetin and pure 
quercetin rutinosides (90).  A study conducted with a 25-year old male volunteer to 
determine absorption of flavonone compounds after administration found that the citrus 
flavonones naringin and hesperidin had low bioavailability (<25%) measured through 
cumulative urinary recovery.  Urinary and plasma levels of narigenin and hesperitin were 
measured in post oral challenges.  These aglycone compounds appeared to be absorbed 
and incorporated into red blood cells.  Narirutin detected in oranges (Citrus sinensis) 
hydrolyzes to the aglycone narigenin.  The primary flavonone in oranges is hesperidin, 
which hydrolyzes to the aglycone hesperitin (88).    
Absorption of the flavonones hesperitin and narigenin allowed for a 5% urine 
recovery from pure compounds.  Higher recovery (24%) of hesperitin from orange juice 
supports the idea that although gastrointestinal absorption of flavonone compound 
occurs, the compound medium might affect degree of absorption (88).   
Not all studies find higher antioxidant capacity in flavonoid aglycone forms.  An 
earlier study reflects this inconsistency.  Comparisons of freeze-dried orange, lemon, and 
grapefruit peel extracts and autooxidation tests demonstrated superior antioxidant 
capacity of orange peel.  Flavonone glycosides hesperidin and naringin appeared to 
account for more effective antioxidation than respective aglycones hesperitin and 
naringenin (91). 
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Despite popular research support for the antioxidant properties of polyphenolic 
compounds, certain polyphenols also pose a risk for damage.  Hydrogen peroxide 
production and generalized oxidative stress is experienced by heavy polyphenol beverage 
drinkers, i.e. coffee, black tea, and green tea.  It is important to recognize properties that 
allow for unexpected outcomes.  Evidence suggests pro-oxidant actions may result from 
interactions of polyphenols and quasi-in vivo environmental conditions (92). 
Research indicates that flavonoids naringin and hesperidin exert both estrogenic 
and antiestrogenic effects.  For example, in vitro estrone sulfatase activity in human liver 
microsomes is inhibited by narigenin, and to a lesser extent hesperitin.  This suggests an 
independent action by these flavonoids to reduce estradiol synthesis may aid in breast 
cancer prevention and offer alternative benefits.  This antiestrogenic activity may seem 
contradictory toward bone health due to estrogen’s role in maintaining bone.  However, 
further study is warranted to delineate complex mechanisms and consequences of 
flavonoid interactions as phytoestrogens (93). 
Estrogenic actions in flavonones hesperidin and naringenin are complex.  In 11 
cases of meningiomas, estrogen binding sites were examined.  Hesperidin did not bind to 
estrogen receptors type II (94).  Estrogen receptor subtype beta interacts with 
phytoestrogen naringenin which competes with estradiol for binding based on weakly 
estrogenic tendencies (95-97).  Consistently contradictory results imply that naringenin 
exerts both antiestrogenic and estrogenic effects dependent upon various factors, such as 
cell context and expression of estrogen receptor alpha gene types.  Agonist vs antagonist 
action depends greatly on cell context and the expressed gene-variant estrogen receptor.  
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Some natural and synthetic estrogens have variable estrogenic or antiestrogenic actions 
(98).   
Bioavailability 
Healthy non-obese adults (n=37, mean age 43 years) participated in a randomly 
assigned, cross-over study to determine bioavailability and plasma biomarkers for 
hesperitin, naringenin, and other bioactive food components.  Designed from a hospital 
menu, a high vegetable diet with 211 g orange juice, one-half orange and one-half 
mandarin each day contained 132 mg hesperitin and 29 mg naringenin daily.  Several 
portions of vegetables including cabbage, cauliflower, broccoli, red pepper, carrots, peas, 
broccoli, kiwi, strawberries or black currants were served daily.  This treatment was 
compared to a low vegetable diet (hesperitin and naringenin, combined <46 mg per day) 
with no citrus fruits or juices added.  After extraction, dietary flavonoids were quantified 
by high-performance liquid chromatography.  Due to methodical limits of the 
quantification, estimated dietary naringenin concentrations were determined by 
multiplying hesperitin content by a factor of 0.22.  Following a baseline period, two five- 
week treatment periods were separated by a three week wash-out interlude.  Analysis of 
flavonoid content was performed through blood collection following an overnight fast, 
extraction, and hydrolysis from plasma proteins.  After the wash-out period, flavonone 
concentrations were below 73 nmol for naringenin and 33 nmol for hesperitin.  Low 
vegetable diet concentrations of average plasma hesperitin and naringenin (12.2 nmol and 
< 1 nmol) increased significantly to 325 nmol and 112.9 nmol following intake of the 
high vegetable diet (p < 0.001 and p < 0.01).  Partially due to a relatively short half-life 
(1.3-2.2 hours), plasma concentrations of naringenin and hesperitin varied among 
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individuals.  Results support the conclusion that hesperitin and naringenin are 
bioavailable in vivo, yet plasma biomarkers are not reliable indicators of intake (99). 
Limonoids  
Although less research has been completed on the antioxidant actions of 
limonoids, these compounds also have the capacity to quench superoxide radicals.  
Limonoids have been shown to stimulate cell apoptosis in cancer cells (100).  
Antioxidant ability is much less effective in limonoids than other citrus compounds, such 
as flavonoids.  Limonin (Lim) and limonin 17-β-D-glucopyranoside (LG) inhibited the β-
carotene-linoleate model system less than 7% compared to 44.4-51.3% by scutellarein, 
kaempferol, and rutin trihydrate.  Free radical scavenging capability assessed by 1,1-
diphenyl-2-picryl hydrazyl showed 0.5% and 2.5% respectively for Lim and LG, while 
formation of superoxide radicals was inhibited by 2.5-10%.  Lim increased lag time of 
hamster low-density-lipoprotein oxidation by three-fold.  Fewer hydroxyl groups are free 
to quench oxygen radicals in these highly oxygenated triterpenoids, hence they are 
weaker antioxidants (82). 
Bone Microarchitecture and Micro-Computed Tomography 
Audran et al.  examined trabecular microarchitecture in 108 men with an 
osteopenic T-score equal or greater than 2.5 SDs below the mean.  Correlations with 
fracture risk indicated a positive relation to trabecular separation and negative relation 
with trabecular number.  Trabecular microarchitecture appears to be an important risk 
factor for fracture in men with osteoporosis (101).  Bone quality involves more than just 
bone mineral density.  Bone strength is affected by the morphometric and material 
properties of bone.  Increased trabecular number and decreased separation contribute 
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greatly to strength through improved structure.  Stiffness of bone refers to the bone’s 
initial reaction to a load.  Stiffness relates to the bending of a bone to avoid fracture or the 
failure that occurs in fracture, known as buckling (7).   
Bone volume fraction, expressed as a percentage, refers to the number of voxels 
defined as bone in the volume of interest (VOI) region analyzed.  Trabecular thickness 
approximates trabecular thinning.  The number of trabeculae that may be removed before 
separating the network completely refers to connectivity density.  Connections are 
important for providing an adequate framework for cancellous mineralization.  During 
the progression of osteoporosis, connectivity is reduced.  Structural Model Index (SMI) 
refers to the plate-like or rod-like characteristics of bone (102).  The index ranges from 
zero to three.  An SMI of zero appears to be purely plate-like, while an SMI of three is 
purely rod-like (103).  Microcomputed tomography and biopsy histomorphometry of 10 
normal premenopausal Korean women correlated in bone volume and SMI parameters, 
although some other parameters are not correlated well.  Caution would dictate that 
micro-CT be used as a complementary analysis tool to ensure accuracy in bone quality 
studies (104).   
Bone Strength and Finite Element Analysis 
Finite Element Analyses (FEA) seek to describe stress and strain components of 
bone (102).  High-resolution images are acquired by utilizing micro-computed 
tomography (μCT) system evaluations to create a voxel model in the 3-D finite element 
analysis.  FEA allows for determination of fracture failure risk based on this computer 
simulation.  Parameters of interest include force for compression, average strain, rigidity 
or stiffness, cross-sectional area, size-independent stiffness, and Von Mises stress.  Force 
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implies the amount of force necessary to completely crush the bone (105, 106).  Load per 
unit area and fractional change in length are known as stress and strain parameters, 
respectively (107).  The internal stress a bone experiences during a load is approximated 
























MATERIALS AND METHODS 
Animals 
One-year-old retired breeder Sprague-Dawley rats (n=40) served as a model of male 
osteoporosis induced by orchidectomy procedures (ORX).  Rats were acclimated to 12 
hour light/dark cycles in an environmentally controlled laboratory and fed an established 
laboratory diet (Table 1, AIN-93M, Teklad, Madison, WI) two days prior to surgery.  
Similar weight animals were randomly assigned to five groups.  After surgery, rats were 
stabilized with the same diet for three days preceding initiation of their treatment diets for 
a period of four months.  Rats were pair-fed based on the mean food intake of SHAM 
(surgery performed without the removal of testes) animals (design shown in appendix 
Figure 1). 
Surgical Procedures 
Rats were orchidectomized (ORX) to induce bone loss through a loss of gonadal 
function.  Using aseptic procedures, animals were anesthetized using a mixture of 
ketamine (100 mg/kg body weight) and xylazine (5 mg/kg body weight).  While lying on 
their back, the scrotal skin was carefully cleaned using 70% ethanol and 0.1% betadine 
and a 1 cm incision at the tip of the scrotum was made.  Following clearing of 
subcutaneous connective tissue and slicing a 5 mm opening in the tip of the scrotal sac, 
gonadal tissue was pulled through and removed.  In addition to removal of the testes,
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other structures were pulled through the incision including the caudal epididymis, caput 
epididymis, vas deferens, and spermatic blood vessels.  Removal of the testes and 
epididymis was continued as a single ligature was placed around the blood vessels and 
the vas deferens.  Remaining vas deferens and fat were replaced in the sac.  Surgical 
wounds were closed with a single suture and tissue adhesive.  Sham-operated (SHAM) 
rats were treated the same as the ORX groups without the removal of testes and 
epididymis. Animals were monitored on a daily basis.  
Diet Composition 
Rats were fed isonitrogenous, isocaloric, semi-purified, powdered casein-based 
treatment diets (modified AIN-93M, Teklad, Madison, WI, Table 1).  Naval oranges 
(Citrus sinensis) were freeze-dried to obtain a sample of powdered orange pulp (OP) to 
add to treatment groups.  Analysis of orange pulp nutrient composition was performed 
(Midwest Laboratories Inc., Omaha, Nebraska).  Basal dietary components were 
manipulated as OP was added to maintain similar contents of fiber, calcium, and 
phosphorus.  Deionized water was provided ad libitum.
Experimental Design 
 Rats were assigned to the following treatments for four months:  SHAM, 
ORX_0_OP, ORX_2.5_OP, ORX_5_OP, and ORX_10_OP.  OP is the amount of 
powdered orange pulp as a percentage of total diet weight.  Throughout the study, the 
ethical care and treatment of animals guidelines from the Animal Care and Use 





Necropsy and Tissue Collection  
Following the four month treatment period, rats were necropsied. A 100:5 mg/kg 
body weight ketamine:xylazine mix was utilized to anesthetize the rats. Blood samples 
were collected from the abdominal aorta. Samples were centrifuged (4°C) at 1500 x g for 
15 minutes to separate sera for analysis (within four hours of necropsy) of alkaline 
phosphatase (ALP) and tartrate-resistant acid phosphatase (TRAP). Remaining sera were 
stored for further analyses. Fourth lumbar vertebrae and left tibias were isolated and 
frozen at -20°C until analyzed. 
Analytical Procedures:   
Serum Antioxidants, ALP, and TRAP 
 These analyses were conducted at Texas A&M University – Kingsville.  Total 
antioxidant concentrations in plasma samples were quantified using a commercially 
available kit (Calbiochem, San Diego, CA).  Total antioxidant status was determined 
spectrophotometrically by measuring at 600 nm the degree of inhibition of the oxidation 
of ABTS (2,2’-Azino-di-[3-ethylbenzthiazolinesulphonate]) to ABTS+ by metmyoglobin 
(a peroxidase).  The amount of ABTS+ formed reflects the concentration of antioxidants 
(Miller NJ, 1993).   
Indices of bone formation (alkaline phosphatase activity) and bone resorption 
(tartrate-resistant acid phosphatase activity) in plasma also were determined using 




Bone Analyses  
Bone density and quality assessments were conducted. Parameters were assessed 
using dual energy x-ray absorptiometry (DXA), micro-computed tomography (µCT) and 
finite element analyses (FEA).   
Dual Energy X-Ray Absorptiometry (DXA) 
Bone mineral area, bone mineral content, and bone mineral density were evaluated 
via dual-energy x-ray absorptiometry using high resolution software designed for analysis 
of small animal bones (DXA; QDR-4500A Elite; Hologic Inc., Waltham, MA).  Prior to 
scanning, the fourth lumbar vertebrae were placed in deionized water in standard 
orientation in plastic weighing boats.  Tibias were scanned dry and were also placed in a 
consistent orientation. 
Micro-Computed Tomography (μCT) Analysis of 4th Lumbar Vertebra and Left Tibia  
Analysis of treatment effects on bone microarchitecture was performed using micro-
computed tomography (μCT) methods.  μCT imaging of left tibial metaphysis and 4th 
lumbar vertebra was performed with a μCT 40 scanner (Scanco Medical AG, Zurich, 
Switzerland).  Using an integration time of 150 milliseconds per projection, scanning was 
completed using medium resolution with 55kVP energy, 144μA current ending in an 
isotropic voxel resolution of 16 microns.  The operator was blinded to the treatment for 
the analyses. Bones were scanned in a 16 mm plastic tube from the proximal growth plate 
in the distal direction (16μm/slice). Approximately 400 (16μm/slice) slices resulted from 
scanning 4th lumbar vertebra from the caudal to the dorsal end. Total contoured slices for 
L-4 vertebra averaged 249 slices. Volume of interest (VOI) evaluations for tibias were 
based on selected regions beginning 20 slices from the growth plate at the proximal end 
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and continuing for 100 slices. The VOI for the midshaft evaluations of cortical bone was 
based on 30 slices. 
 Bone morphometric parameters were acquired through VOI evaluations.  
Parameters of interest focused on bone volume fraction (BV/TV), trabecular number (Tb. 
N.), trabecular separation (Tb. Sp.), trabecular thickness (Tb. Th.), connectivity density 
(Conn. D.), structural model index (SMI), and cortical thickness (Cort. Th.).  Trabecular 
regions were selected to include secondary spongiosa located 330 μm and 165 μm from 
the growth plate for L-4 and tibia scans, respectively.  Lumbar vertebra and tibia 
evaluations were segmented using a Gaussian filter (sigma 0.7, support 1) to remove 
noise and a fixed threshold level of 240 to obtain a 3-D bone structure.  Tibia midshaft 
evaluations used a fixed threshold level of 280. 
Finite Element Analysis 
 Following micro-architecture assessment of 4th lumbar vertebra and left tibias by 
microcomputed tomography, finite element analyses were performed. Parameters of 
interest included average strain (Av strain), von Mises stress (VM Stress), force for 
compression (physiological force), stiffness (Stiff), cross-sectional area (XSec Area), and 
size-independent stiffness (Ind Stiff). 
Statistical Methods 
 DXA, microarchitecture, and FEA measurements were compiled in Excel and 
data were analyzed using the Statistical Analysis System (SAS version 9.1).  The 
Generalized Linear Model (GLM) procedure was followed by Fisher’s Least Significant 
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ABSTRACT   1 
 This study evaluated the effects of feeding orange pulp (OP) on bone quality in a 2 
rat model of male osteoporosis. One-year-old retired breeder rats were randomly assigned 3 
to orchidectomy (ORX) 5 or sham-surgery (SHAM) treatments. Three days post-surgery, 4 
ORX rats were assigned to the following treatments: ORX, ORX_2.5_OP, ORX _5_OP 5 
and ORX _10_OP. Diets were isonitrogenous, isocaloric modified AIN-93M diets with 6 
equal fiber content. All ORX rats were pair fed for four months to the mean food intake 7 
of SHAM. At the end of the study, blood and bone samples were collected. Plasma 8 
antioxidant capacity was determined spectrophotometrically. Bone density, structure, and 9 
strength were assessed using dual energy X-ray absorptiometry, microcomputed 10 
tomography, and finite element analyses. Least square means procedure was used to 11 
separate treatment differences (p<0.05). Orchidectomy decreased (p<0.05) antioxidant 12 
status while OP as low as 2.5% maintained antioxidant capacity of ORX rats to that of 13 
SHAM. In 4th lumbar trabecular cores, ORX rats had significantly reduced bone volume 14 
fraction, connectivity density, and trabecular number and increased trabecular separation. 15 
Ten percent OP tended (p<0.07) to increase bone volume fraction and trabecular number, 16 
as well as to decrease trabecular separation compared to ORX. ORX consistently had 17 
negative impacts on bone density, structure, and strength parameters. Improvements in 18 
microarchitectural properties of L-4 vertebral and tibial bones due to orange pulp are 19 
evidenced by trends toward increased bone volume fraction, connectivity density and 20 
decreased trabecular separation in ORX_10_OP rats compared to ORX rats. Dietary 21 
orange pulp induced subtle favorable changes in bone.  22 
KEY WORDS:  orange • osteoporosis • orchidectomy • microcomputed tomography 23 
(μCT) • finite element analysis (FEA) 24 
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INTRODUCTION 25 
 According to the National Institutes of Health’s Osteoporosis and Related Bone 26 
Diseases Resource Center, approximately ten million people are affected by osteoporosis 27 
each year and twenty percent of these are men (1). This condition of porous bone is 28 
distinguished by a loss of bone mass, structure, and strength. Excessive bone resorption, 29 
inadequate bone formation, and a failure to reach peak bone mass during growth and 30 
development increase the likelihood of experiencing osteoporosis. 31 
 Osteoporosis in men has become a more significant threat to health as life-span 32 
has increased. Male hormone deficiency appears to have similar consequences as female 33 
hormone deficiency, although it often occurs later in life (2). Males who experience 34 
severely low gonadal function over time are at increased risk for developing osteoporosis. 35 
Deterioration of trabecular bone mass is associated with low testosterone levels in males 36 
(3). Similar to a postmenopausal lack of estrogen, androgen loss has a negative effect on 37 
bone maintenance. Compared to sham-operated Fisher 344 rats 13 months of age, 38 
orchidectomized (ORX) equivalents experienced a 7% loss of bone mineral density 39 
(BMD) over 180 days (4).  40 
 Mortality rates in men post hip fractures are twice as high as rates in women (5-41 
6). In men whose fractures result in hospitalization, almost one in ten dies (8% mortality 42 
rate), while only about one in 30 women die during hospitalization for fracture (7).  43 
 Prevention of osteoporosis focuses on increasing peak bone mass at an early age 44 
and maintaining bone mass later in life. Treatments may include lifestyle modifications 45 
(including dietary habits) and pharmaceuticals (8). Vitamins and minerals are important 46 
in maintaining optimal skeletal health (9). Citrus fruits contain many flavonoids in 47 
addition to important nutrients and other food components, including Vitamin C and 48 
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potassium. Due to their phenolic properties, flavonoids interact uniquely within 49 
membranes and offer protection from the harmful effects of lipid peroxidation and free 50 
radicals (10). The citrus flavonoid hesperidin inhibits bone loss through reduction of 51 
osteoclast number and through improved mineralization of calcium, phosphorus, and zinc 52 
(11). Naringin, another citrus flavonoid, increases bone formation when bone grafts are 53 
incorporated with naringin in collagen matrix (12). Citrus antioxidant studies appear to 54 
confirm the role for bone health of an overall health-conscious diet similar to the USDA 55 
Dietary Guidelines recommendations (13). The aim of this study was to examine the 56 

















MATERIALS AND METHODS 73 
Animals and diets 74 
 One-year-old retired breeder Sprague-Dawley rats (n=40) served as a model of 75 
male osteoporosis induced by orchidectomy procedures (ORX). Rats were acclimated to 76 
12 hour light/dark cycles in an environmentally controlled laboratory and fed a semi-77 
purified diet (Table 1, AIN-93M, Teklad, Madison, WI) for two days prior to surgery. 78 
Similar weight animals were randomly assigned to five groups. Following surgery, 79 
animals were stabilized with the same diet for three days preceding initiation of 80 
experimental diet treatments.  81 
Surgery 82 
 Rats were orchidectomized to induce bone loss. Using aseptic procedures, animals 83 
within ORX groups were anesthetized for surgical removal of the testes and epididymis 84 
using a combination of ketamine (100 mg/kg body weight) and xylazine (5 mg/kg body 85 
weight). Sham-operated (SHAM) rats were treated the same as the ORX groups without 86 
the removal of testes and epididymis.  87 
Experimental Design 88 
 Rats were assigned to the following treatments for four months:  SHAM, 89 
ORX_0_orange pulp (OP), ORX_2.5_OP, ORX_5_OP, and ORX_10_OP. OP is the 90 
amount of powdered orange pulp as a percentage of total diet weight. Throughout the 91 
study, the ethical care and treatment of animals guidelines from the Animal Care and Use 92 
Committee of Texas A&M University-Kingsville were followed. 93 
Diet Composition 94 
 Rats were fed the experimental diets three days post-surgery. Experimental diets 95 
were isonitrogenous, isocaloric, casein-based diets modified from the American Institute 96 
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of Nutrition’s (AIN-93M) maintenance formulation (Table 1). Naval oranges (Citrus 97 
sinensis) were freeze-dried to obtain powdered orange pulp to add to treatment groups. 98 
Analysis of orange pulp nutrient composition was performed (Midwest Laboratories Inc., 99 
Omaha, Nebraska) and basal dietary components were manipulated as orange pulp was 100 
added to maintain similar concentrations of fiber, calcium, and phosphorus. Deionized 101 
water was provided ad libitum. 102 
Necropsy and tissue collection  103 
 Following the four month treatment period, rats were necropsied. A 100:5 mg/kg 104 
body weight ketamine:xylazine mix was utilized to anesthetize the rats. Blood samples 105 
were collected from the abdominal aorta. Samples were centrifuged (4°C) at 1500 x g for 106 
15 minutes to separate sera for analysis (within four hours of necropsy) for activities of 107 
alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TRAP). Remaining 108 
sera were stored for further analyses. Fourth lumbar vertebrae and left tibias were isolated 109 
and frozen at -20°C until analyzed.  110 
Analytical Procedures:  Serum Antioxidants, ALP, and TRAP 111 
 These analyses were conducted at Texas A&M University – Kingsville. Total 112 
antioxidant concentrations in plasma samples were quantified spectrophotometrically 113 
using a commercially available kit (catalogue # 615700, Calbiochem, San Diego, CA). 114 
Indices of bone formation (alkaline phosphatase activity) and bone resorption (tartrate-115 
resistant acid phosphatase activity) in plasma also were determined using commercially 116 
available kits (Thermo Electron, Louisville, CO).  117 
Bone Analyses:   Dual Energy X-Ray Absorptiometry (DXA) 118 
 Bone mineral area, bone mineral content, and bone mineral density were 119 
evaluated via dual-energy x-ray absorptiometry using high resolution software designed 120 
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for analysis of small animal bones (DXA; QDR-4500A Elite; Hologic Inc., Waltham, 121 
MA). Prior to scanning, the fourth lumbar vertebrae were placed in deionized water in 122 
standard orientation in plastic weighing boats.  Tibias were scanned dry and were also 123 
placed in a consistent orientation. 124 
Microcomputed Tomography (μCT) Analysis of 4th Lumbar Vertebra and Left Tibia  125 
Micro-computed tomography (μCT) imaging of left tibial metaphysis and 4th lumbar 126 
vertebra was performed with a μCT 40 scanner (Scanco Medical AG, Zurich, 127 
Switzerland). Using an integration time of 150 milliseconds per projection, scanning was 128 
completed using medium resolution with 55kVP energy, 144μA current with an isotropic 129 
voxel resolution of 16 microns. The operator was blinded to the treatment for the 130 
analyses. Bones were scanned in a 16 mm plastic tube from the proximal growth plate in 131 
the distal direction (16μm/slice). Approximately 400 (16μm/slice) slices resulted from 132 
scanning 4th lumbar vertebra from the caudal to the dorsal end. Total contoured slices for 133 
L-4 vertebra averaged 250 slices, with volume of interest evaluations (VOI) based on 134 
selected regions of secondary spongiosa beginning 10 slices from the growth plate at the 135 
proximal end. VOI evaluations for tibias were also based on selected regions of 136 
secondary spongiosa beginning 35 slices from the growth plate bridge at the proximal 137 
end and continuing for 100 slices. The VOI for the midshaft evaluations of cortical bone 138 
was based on 30 slices. 139 
 Bone morphometric parameters were acquired through VOI evaluations. 140 
Parameters of interest focused on bone volume fraction (BV/TV), trabecular number (Tb. 141 
N.), trabecular separation (Tb. Sp.), trabecular thickness (Tb. Th.), connectivity density 142 
(Conn. D.), structural model index (SMI), and cortical thickness (Cort. Th.). Lumbar 143 
vertebra and tibia evaluations were segmented using a Gaussian filter (sigma 0.7, support 144 
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1) to remove noise and a fixed threshold level of 240 to obtain a 3-D bone structure. 145 
Tibial midshafts were analyzed using a fixed threshold level of 280. 146 
Finite Element Analysis 147 
 Following micro-architecture assessment of 4th lumbar vertebra and left tibias by 148 
microcomputed tomography, finite element analyses were performed. Parameters of 149 
interest included average strain, Von Mises stress, force for compression, stiffness, cross-150 
sectional area, and size-independent stiffness. 151 
Statistical Methods 152 
 Data were compiled in Excel and analyzed using the Statistical Analysis System 153 
(SAS version 9.1, Cary, NC). The Generalized Linear Model (GLM) procedure was 154 
followed by Fisher’s Least Significant Difference test for means separation. Significance 155 















Serum Antioxidants, ALP and TRAP  170 
 Antioxidant capacity was significantly decreased in ORX rats receiving the 171 
standard diet only.  In all ORX groups fed orange pulp levels of total antioxidant capacity 172 
was restored to the level of SHAM. ALP activity was not significantly affected by 173 
treatment. TRAP activity was significantly increased in the ORX_10_OP group 174 
compared to the SHAM, ORX, and ORX_2.5_OP groups (Table 2).  175 
Bone Mineral Area, Content, and Density 176 
 In 4th lumbar vertebrae (L-4) and left tibia DXA scans, ORX rats had 177 
significantly reduced bone mineral area and content regardless of treatment (Table 3, 178 
Figs. 1-4). Bone mineral density (BMD) was not significantly affected by ORX or dietary 179 
orange pulp levels in either bone (Figs. 5-6). 180 
μCT Analyses 181 
 Within L-4 vertebral trabecular cores, ORX significantly decreased bone volume 182 
fraction, connectivity density, and trabecular number (Figs. 7-9), and increased trabecular 183 
separation (Table 4, Fig. 10) (p=0.01) compared to SHAM. In ORX_10_OP rats, mean 184 
measurements of the above parameters were not significantly different from SHAM. Ten 185 
percent orange pulp tended (p<0.07) to improve the same parameters excluding 186 
connectivity density compared to ORX. 187 
 In left proximal tibia trabecular cores, all ORX rats regardless of treatment had 188 
significantly reduced total volume, bone volume (not shown), connectivity density and 189 
trabecular number and tendencies toward increased trabecular separation (p=0.06) 190 
(Figs.11-14). ORX_10_OP showed tendencies to improve bone volume fraction 191 
compared to other ORX groups (Fig. 15). Decreases in total area at midshaft and cortical 192 
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bone area at midshaft in all ORX groups were significant (Figs. 16-17). Tibial midshaft 193 
bone area was reduced in ORX_0_OP, ORX_2.5_OP, and ORX_5_OP groups compared 194 
to SHAM (p= 0.006, Table 5). ORX_10_OP restored bone area to be statistically 195 
equivalent to the size of SHAM and tended to increase bone area compared to 196 
ORX_0_OP (p=0.08).  197 
FE Analyses 198 
Strength assessments in 4th lumbar vertebrae and left proximal tibias, yielded 199 
some significantly reduced parameters in ORX compared to SHAM (Tables 6, 7). L-4 200 
ORX_0_OP showed more than 50% decrease in average strain (not shown), force for 201 
compression (Figs. 18-19), stiffness (not shown), and size-independent stiffness (Figs. 202 
20-21) measurements compared to SHAM. Tibial ORX_0_OP showed decreases in 203 
average strain (19%, not shown), force for compression (43%, Figs. 18-19), stiffness 204 
(43%, not shown), cross-sectional area (10%, Fig. 22), size-independent stiffness (36%, 205 
Figs. 20-21), and Von Mises Stress (29%) measurements compared to SHAM (p<0.04).  206 
No significant differences in tibial FE analyses were seen between ORX and all 207 
ORX groups fed orange pulp with the exception of cross-sectional area which decreased 208 
with OP. However, the 10% dietary orange group tended to show improvements in many 209 
vertebral bone parameters including force for compression, average strain, and size-210 
independent stiffness compared to ORX. Tibial bones in the 10% orange pulp group 211 
tended to show increases for size-independent stiffness compared to ORX, and the mean 212 






 This study assessed bone quality in orchidectomized male rats fed orange pulp for 218 
four months. The improvements in some measures of bone structure suggest potential 219 
benefits for orange in improving bone health. One mechanism by which orange exerts 220 
beneficial effect is through relief of oxidative stress. Antioxidant status of ORX rats was 221 
restored to levels of the SHAM (p<0.05) by feeding orange pulp, even at the lowest 222 
concentration.  223 
Orchidectomy results in a loss of gonadal function in males. Literature suggests 224 
this loss of function negatively impacts bone health and increases risk of fracture (18). 225 
μCT analysis showed a significant decline in bone structure in orchidectomized rats. As a 226 
model for inducing bone loss in males, orchidectomy successfully reduced measures of 227 
bone density, structure, and strength. This confirms efficacy as an animal model for 228 
studying male osteoporosis.  229 
 Feeding orange pulp to orchidectomized rats improved some bone characteristics; 230 
however, small sample size or weight variations limit sensitivity of results. In DXA 231 
analyses, significant changes were seen in bone mineral area and bone mineral content. 232 
While trends showed a positive effect on bone mineral density, means were not 233 
significantly different. Results support a possible threshold effect in that ten percent 234 
dietary orange pulp consistently tended to improve μCT measures of bone parameters 235 
compared to ORX animals fed the standard diet. Finite element analyses of fourth lumbar 236 
vertebra suggested possible improvements in bone parameters in ORX_10_OP animals 237 
compared to ORX_0_OP animals but these were not significant differences.  238 
 In the present study, despite trends to improve some characteristics of bone 239 
structure, effects of feeding orange pulp to orchidectomized rats were not statistically 240 
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significant. Components of citrus likely to produce the subtle beneficial effect observed 241 
include flavonoids, (specifically hesperidin and narigenin), limonoids, and vitamin C.  242 
Flavonoids (i.e. hesperitin, naringenin), limonoids, vitamin C, and potassium are 243 
bioactive components within oranges that may improve bone health through increasing 244 
antioxidant status, promoting collagen formation, and maintaining an alkaline 245 
environment (9, 11-12, 15-16). Benefits likely related to antioxidants include bone 246 
resorption protection and bone formation mechanism activation (10, 13, 17). Flavonoids 247 
act to spare vitamin C from oxidation, in addition to independent antioxidant capabilities 248 
(18). Through direct and indirect antioxidant action, components may reduce oxidative 249 
stress in vivo and alleviate stimulation of bone resorption (19). However, in the present 250 
study, high levels of TRAP observed in all ORX groups suggest feeding orange pulp did 251 
not inhibit TRAP activity likely due to the rigorous negative effects of orchidectomy on 252 
bone.  253 
Endocrine effects of narigenin and hesperitin may partially account for benefits to 254 
bone health. Even in men, estrogen is important for maintaining bone and preventing 255 
resorption (20). Estrogenic and antiestrogenic actions by hesperidin and naringin are 256 
complex. As phytoestrogens glycone flavonoids, hesperitin and naringenin, are important 257 
in preventing bone loss.  258 
Flavonones contribute to increased plasma levels of free estradiol. Xenoestrogens, 259 
such as naringenin and genistein, act as ligands to increase free plasma levels of 260 
endogenous testosterone and estradiol through displacement from human plasma sex-261 
hormone binding globulin (21). Furthermore, estrogen elimination is inhibited by 262 
flavonones hesperitin and naringenin. Inhibition of glucuronidase reduces liver 263 
metabolism and elimination of estrogen. This reduction in estrogen metabolism should 264 
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translate to reduced bone resorption (22). Hesperidin has been shown to inhibit bone loss 265 
in ovariectomized mice through reduction in osteoclast number (11).  266 
  Increasing dietary consumption of functional foods, including oranges, provides 267 
an inexpensive strategy for maintaining bone health. Literature suggests bioactive 268 
components benefit bone structure through antioxidant and estrogenic actions. Although 269 
improvements are subtle, this study supports the USDA recommendation to consume a 270 
wide variety of fruits and vegetables daily (13).  271 
Conclusion 272 
 Data showed that orchidectomy significantly reduced parameters of bone density, 273 
structure, and strength in year-old rats over a four-month period. ORX_10_OP tended to 274 
positively affect some parameters of bone density, structure, and strength. Effects of 275 
lower dietary intakes of orange pulp are not easily discerned from our results. 276 























5Abbreviations used: OP, orange pulp; ORX, orchidectomy; ORX_0_OP, ORX + 0% 
OP; ORX_2.5_OP, ORX + 2.5% OP; ORX_5_OP, ORX + 5.0% OP; ORX_10_OP, ORX 
+ 10.0% OP; SHAM, sham-operated; BMC, bone mineral content; BMA, bone mineral 
area; BMD, bone mineral density; μCT, microcomputed tomography; FEA, finite 
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Composition of Diets  1,2, 3 
 
           
     Orange pulp (%)    
      
Ingredients (g/100g diet)    Control diet            2.5                       5                            10  
 
      Corn starch                   45.5            43.47                   41.5   37.40 
      Maltodextrin      15.5         15.5                     15.5   15.5  
      Sucrose       10.73                10.73                   10.73               10.73  
      Orange pulp1      -----         2.5           5.0                          10.0 
      Casein                                       14.45         14.23                   14.02               13.58 
      Cystine                    0.2            0.2           0.2   0.2 
      Soybean oil                    4.6           4.5                    4.31               4.08 
      Fiber               5.0                     4.89                   4.79               4.58 
      Vitamin premix2                        1.0         1.0           1.0   1.0 
      Trace mineral3                   1.34         1.34             1.34                        1.34 
      Choline chloride                        0.20                       0.20                     0.20                        0.20 
      Calcium carbonate                   0.61                       0.60                    0.59                        0.57  
      Dicalcium phosphate     0.873         0.86           0.85   0.82 
 
       Total calorie/Kg diet    3,675        3,675          3,675               3,677 
       Protein (%)      12.62        12.62           12.62                  12.62 
 
 
1Orange Pulp Composition (total calorie per gram 3,854; crude protein 7.62%; crude fat 
1.61%; acid detergent fiber 4.23%; phosphorous 0.18%; magnesium 0.09%; calcium 0.31%; 
iron 11 ppm; manganese 2 ppm; copper 4 ppm; zinc 5 ppm 
2Vitamin Mixture Composition (AIN-93; Harlan Teklad, Madison, WI).  
3
Mineral Mixture Composition (g/Kg mix; Harlan Teklad, Madison, WI). magnesium oxide, 
24g, Ferric citrate, 6.06g; zinc carbonate, 1.65g; manganous carbonate, 0.63g; cupric 
carbonate, 0.3g; potassium iodate, 0.01g; sodium selenate, 0.01g; ammonium 
paramolybdate, 0.007g; chromium potassium sulfate 0.275g; boric acid, 0.0815; sodium 
fluoride, 0.0635g; nickel carbonate, 0.0318g; ammonium vanadate, 0.0066g.  
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TABLE 2 




_____________________________ORX_Orange Pulp (%)_________________________________ 
            0%                                2.5%                                    5.0%                                    10.0%       
Antioxidant capacity 
(nM) 
1.23+0.03a 1.09+0.03 b 1.25+0.03 a 1.25+0.03 a 1.26+0.03 a 
ALP activity (U/L) 32+6.0 43+6.0 34+8.0 31+7.0 41+6.0 
TRAP activity (U/L) 4.7+0.62 b 6.3+0.82 b 5.9+0.73 b 7.1+0.94 ab 8.4+0.62 a 
 
 
1Measurements based on serum analysis by collaborators at Texas A&M University-Kingsville. 
2Means ± SEM ( n = 9).   

















Effects of orchidectomy and feeding orange pulp on DXA measurements of L4 and tibial bone mineral area, content 






_____________________________ORX_Orange Pulp (%)_________________________________ 
            0%                                2.5%                                   5.0%                                   10.0%        
 
p-values 
L4 Vertebra (n=39)       
   Bone Mineral Area, cm 2 0.828 ± 0.033 a 0.725 ± 0.013 b  0.703 ± 0.013 b   0.705 ± 0.019 b  0.721 ± 0.026 b  0.0012 
   Bone Mineral Content, g 0.230 ± 0.008 a 0.194 ± 0.006 b  0.190 ± 0.007 b 0.191 ± 0.008 b  0.205 ± 0.009 b  0.0048 
   Bone Mineral Density, g/cm 2 0.278 ± 0.005 0.268 ± 0.008  0.269 ± 0.006  0.271 ± 0.006  0.284 ± 0.005  0.3377 
Left Tibia (n=42) 
 
      
   Bone Mineral Area, cm 2 2.30 ± 0.05 a 2.06 ± 0.03 b 2.01 ± 0.05 b 2.05 ± 0.05 b 2.06 ± 0.05 b 0.0005 
   Bone Mineral Content, g 0.600 ± 0.019 a 0.511 ± 0.014 b 0.498 ± 0.017 b 0.520 ± 0.019 b 0.528 ± 0.019 b 0.0024 
   Bone Mineral Density, g/cm 2 0.259 ± 0.005 0.247 ± 0.004 0.247 ± 0.004 0.253 ± 0.004 0.256 ± 0.004 0.1793 
 
1Means ± SEM ( n = 7-9).   








Effects of orchidectomy and feeding orange pulp on μCT measurements of L4 vertebral bone volume fraction, 




1Means ± SEM, (n = 7-8).   












____________________________ORX_Orange Pulp (%)_________________________________ 
            0%                                2.5%                                   5.0%                                   10.0%       
 
p-values 
L4 Vertebra Microarchitecture    
  Total Volume,  mm3 
 
23.37 ± 1.75 
 
22.56 ± 1.35 
 
23.75 ± 0.54 
 
22.50 ± 1.95 
 
19.43 ± 1.46 
 
0.3241 
  Bone Volume,   mm3 5.40 ± 0.44 4.15 ± 0.36 4.37 ± 0.34 4.33 ± 0.50 4.24 ± 0.36 0.1963 
  Bone Volume/Total Volume, % 23.3 ± 1.5 a 18.5 ± 1.3 bc 18.3 ± 1.1 c 19.1 ± 1.0 bc 21.8 ± 0.7 ab 0.0135 
  Connectivity Density, 1/mm3 40.2 ± 3.8 a 27.4 ± 2.8 b 28.0 ± 4.2 b 27.0 ± 2.2 b 32.9 ± 2.7 ab 0.0311 
  Structural Model Index 0.80 ± 0.13 1.11 ± 0.10 0.96 ± 0.08 1.03 ± 0.11 0.93 ± 0.06 0.2595 
  Trabecular Number,  1/mm 3.170 ± 0.164 a 2.512 ± 0.153 bc 2.423 ± 0.206 c 2.587 ± 0.078 bc 2.925 ± 0.085 ab 0.0049 
  Trabecular Thickness,  mm 0.086 ± 0.003 0.086 ± 0.002 0.085 ± 0.002 0.087 ± 0.002 0.087 ± 0.002 0.9774 
  Trabecular Separation,  mm 0.311 ± 0.016 c 0.411 ± 0.029 ab 0.441 ± 0.043 a 0.385 ± 0.014 abc 0.337 ± 0.011 bc 0.0073 
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TABLE 5 
Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial bone volume, connectivity density, 
total area at midshaft, bone area, marrow area,  and tibial length in year-old Sprague-Dawley rats 1,2 
 
 
1Means ± SEM, (n = 8-9).   





            0%                                2.5%                                    5.0%                                    10.0%    
 
p-values 
Proximal Tibial Microarchitecture 
  Total Volume,  mm3 
 
34.43 ± 1.12 a 
 
30.94 ± 1.12 b   
 
27.65 ± 0.78 c  
 
27.91 ± 1.06 c   
 
25.14 ± 0.66 c   
<0.0001 
  Bone Volume,   mm3 5.61 ± 0.54 a 4.01 ± 0.26 b    3.62 ± 0.38 b   3.66 ± 0.26 b   3.79 ± 0.27 b   0.0015 
  Bone Volume/Total Volume, % 16.2 ± 1.2 13.0 ± 0.8  13.1 ± 1.3   13.0 ± 0.5  15.1 ± 1.0  0.0916 
  Connectivity Density, 1/mm3 32.2 ± 3.0 a 22.0 ± 2.9 b   20.2 ± 2.8 b   19.8 ± 1.6 b 23.2 ± 2.2 b   0.0098 
  Structural Model Index 2.01 ± 0.08 2.20 ± 0.06  2.11 ± 0.13  2.21 ± 0.04   2.07 ± 0.10  0.4017 
  Trabecular Number,  1/mm 2.891 ± 0.169 a 2.34 ± 0.15 b   2.23 ± 0.13 b   2.20 ± 0.09 b   2.44 ± 0.14 b   0.0091 
  Trabecular Thickness,  mm 0.085 ± 0.005 0.087 ± 0.002  0.087 ± 0.003  0.091 ± 0.003  0.090 ± 0.003  0.6271 
  Trabecular Separation,  mm 0.344 ± 0.028 0.439 ± 0.036  0.458 ± 0.030  0.450 ± 0.022  0.406 ± 0.027  0.0594 
Tibial Midshaft Microarchitecture       
  Cortical Thickness, mm 0.669 ± 0.015 0.628 ± 0.009 0.645 ± 0.015 0.642 ± 0.011 0.669 ± 0.013 0.1144 
  Total Area at Midshaft,  mm2  6.762 ± 0.146 a 5.843 ± 0.136 b 5.783 ± 0.204 b 5.873 ± 0.159 b 6.105 ± 0.166 b 0.0008 
     Bone Area, mm 4.755 ± 0.100 a 4.145 ± 0.098 b 4.196 ± 0.161 b 4.221 ± 0.112 b 4.452 ± 0.130 ab 0.0059 
     Marrow Area,  mm 2.007 ± 0.112 a 1.698 ± 0.047 b 1.587 ± 0.056 b 1.652 ± 0.066 b 1.652 ± 0.055 b 0.0016 
Tibia Length  46.95 ± 0.38 45.76 ± 0.35 45.61 ± 0.53 45.81 ± 0.36 45.73 ± 0.46 0.1793 
 57 
TABLE 6 
Effects of orchidectomy and feeding orange pulp on finite element analyses of L-4 trabecular bone strain, physiological 





____________________________ORX_Orange Pulp (%)_________________________________ 
            0%                                2.5%                                   5.0%                                   10.0%       
 
p-values 
Average Strain 0.2001 ± 0.0181a 0.0856 ± 0.0162 b 0.1215 ± 0.0244 b 0.0946 ± 0.0137 b 0.1315 ± 0.0212 b 0.0012 
Force for Compression 6.546 ± 0.810 a 2.109 ± 0.407 b 3.251 ± 0.737 b 2.472 ± 0.520 b 3.431 ± 0.635 b 0.0002 
Stiffness 428403 ± 57621 a 138139 ± 27735 b 220272 ± 54012b 158779 ± 33085 b 222563 ± 42560 b 0.0004 
Cross-Sectional Area 4.549 ± 0.368  4.331 ± 0.178  4.607 ± 0.161  4.314 ± 0.347  3.741 ± 0.230  0.2315 
Size-Independent Stiffness 492.1 ± 69.6 a 170.5 ± 36.6 b 233.0 ± 51.2 b 191.4 ± 36.4 b 300.6 ± 51.6 b 0.0004 
Von Mises Stress 32.30 ± 4.33  52.70 ± 5.95  48.20 ± 6.27  49.34 ± 5.56  47.03 ± 6.77  0.1317 
 
1Means ± SEM, (n = 7-8).   















Effects of orchidectomy and feeding orange pulp on finite element analyses of tibial trabecular bone strain, 
physiological force, stiffness, cross-sectional area, size-independent stiffness, and von Mises stress in Sprague-Dawley 





____________________________ORX_Orange Pulp (%)_________________________________ 
            0%                                2.5%                                   5.0%                                   10.0%       
 
p-values 
Average Strain 0.3059 ± 0.0156 a 0.2481 ± 0.0120 b 0.2417 ± 0.0215 b  0.2189 ± 0.0177 b  0.2472 ± 0.0197 b  0.0191 
Force for Compression 32.917 ± 5.008 a 18.772 ± 1.873 b 17.098 ± 3.411 b  15.320 ± 2.341 b   17.748 ± 2.359 b  0.0023 
Stiffness 657544 ± 100034 a 374983 ± 37408 b  339476 ± 65472 b  307568 ± 47552 b  354531 ± 47121 b  0.0022 
Cross-Sectional Area 57.461 ± 1.874 a 51.623 ± 1.869 b 46.166 ± 1.424 c  46.409 ± 1.723 c  41.944 ± 1.095 c  <0.0001 
Size-Independent Stiffness 188.7 ± 24.5 a 121.0 ± 11.3 b  121.7 ± 21.9 b  107.9 ± 12.9 b  141.2 ± 18.6 ab  0.0292 
Von Mises Stress 4.60 ± 0.36 b 6.51 ± 0.52 a  7.47 ± 0.73 a  7.46 ± 0.56 a  7.18 ± 0.87 a  0.0138 
 
1Means ± SEM, (n = 8-9).   





Effects of orchidectomy and feeding orange pulp on DXA measurements of L4 and tibial bone mineral area in year-old 


































    
 
1Means ± SEM (n = 7-9).   







































FIGURES 3-4.  
Effects of orchidectomy and feeding orange pulp on DXA measurements of L-4 and tibial bone mineral content in year-




































1Means ± SEM (n = 7-9).   







































Effects of orchidectomy and feeding orange pulp on DXA measurements of L4 and tibial bone mineral density in year-











































1Means ± SEM (n = 7-9).   












































FIGURE 7.  
Effects of orchidectomy and feeding orange pulp on μCT measurements of L4 vertebral bone volume fraction in year-































1Means ± SEM (n = 7-8).   










Effects of orchidectomy and feeding orange pulp on μCT measurements of L4 vertebral connectivity density in year-old 



































1Means ± SEM (n = 7-8).   









FIGURE 9.   
Effects of orchidectomy and feeding orange pulp on μCT measurements of L4 vertebral trabecular number in year-old 





































1Means ± SEM (n = 7-8).   










Effects of orchidectomy and feeding orange pulp on μCT measurements of L4 vertebral trabecular separation in year-





































1Means ± SEM (n = 7-8).   










Effects of orchidectomy and feeding orange pulp on μCT measurements of total tibial volume in year-old Sprague-





































1Means ± SEM (n = 8-9).   








Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial connectivity density in year-old 




































1Means ± SEM (n = 8-9).   










Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial trabecular number in year-old 





































1Means ± SEM (n = 8-9).   








Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial trabecular separation in year-old 


































1Means ± SEM (n = 8-9).   








Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial bone volume fraction in year-old 































1Means ± SEM (n = 8-9).   








Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial total area at midshaft in year-old 



































1Means ± SEM (n = 8-9).   








Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial cortical bone area at midshaft in year-



































1Means ± SEM (n = 8-9).   








Effects of orchidectomy and feeding orange pulp on FEA measurements of L4 and tibial force for compression in year-






































    
 
1Means ± SEM (n = 7-9).   












































Effects of orchidectomy and feeding orange pulp on FEA measurements of L4 and tibial size-independent stiffness in 





































    
 
1Means ± SEM (n = 7-9).   










































Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial cross-sectional area in year-old 







































1Means ± SEM (n = 8-9).   







Summary and Conclusions 
 As a model for inducing bone loss in males, orchidectomy successfully reduced 
measures of bone density, structure, and strength.  In our experimental analyses, feeding 
orange pulp to orchidectomized rats appeared to improve some characteristics of bone 
structure, although most were not significantly greater than orchidectomized rats fed only 
the standard diet.  Components of citrus likely to produce this effect include flavonoids, 
(specifically hesperidin and narigenin), limonoids, and vitamin C.  Through direct and 
indirect antioxidant action, components may reduce oxidative stress in vivo and alleviate 
stimulation of bone resorption (110).  Complex estrogenic and antiestrogenic actions by 
hesperidin and naringin contribute to bone maintenance.    Dietary consumption of 
functional foods, including oranges, provide an inexpensive strategy for maintaining bone 
health.  Although improvements are subtle, this study supports the USDA 
recommendation to consume a wide variety of fruits and vegetables daily.  
Suggestions for Further Research 
 Data showed that orchidectomy significantly reduced parameters of bone density, 
structure, and strength in year-old rats over a four-month period.  This confirms efficacy 
as an animal model for studying male osteoporosis.  The ORX_10.0% orange pulp group 
showed positive tendencies toward improved parameters of bone density, structure, and 
 77 
strength.  However, at lower doses, effects are not easily discerned.  Further study is 
warranted to elucidate effects of feeding orange pulp to Sprague-Dawley rats, mechanism 
of action, and ideal dose.  Methodology considerations for future studies include 
determining effects of feeding orange pulp using higher percentages of orange pulp in the 
diet, longer time periods, fresh fruit instead of freeze-dried samples, and a larger sample 
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Composition of Control Diet. 
  Ingredients                Control diet (g/100g diet)                          
 
       Carbohydrate 
        Total           70.95            
        Corn starch                     45.0                
        Maltodextrin          15.5            
     
  Sucrose           10.45                     
                
         
  Protein 
        Total           14.65                 
        Casein                                           14.45                           
        Cystine                                 0.2                
 
         Fat 
         Total       4.6                  
          
  Soybean oil                     4.6                               
               
 
         Fiber 
         Total       5.0                        
               
  Cellulose          5.0                                          
                   
         Vitamin premix1                          1.0           
     
         
  Trace mineral2                     1.34                                   
         Choline                                         0.20                                                   
         Calcium carbonate                     0.61                                              
  Di-calcium phosphate         0.873                                 
        
         Total Calories (Kcal)                    3675.0     
      Total Protein   (%)         12.6175     
 
1Vitamin Mixture Composition (AIN-93M; Harlan Teklad, Madison, WI).  
2
Mineral Mixture Composition (g/Kg mix; Harlan Teklad, Madison, WI). magnesium oxide, 
24g, Ferric citrate, 6.06g; zinc carbonate, 1.65g; manganese carbonate, 0.63g; cupric 
carbonate, 0.3g; potassium iodate, 0.01g; sodium selenate, 0.01g; ammonium paramolybdate, 
0.007g; chromium potassium sulfate 0.275g; boric acid, 0.0815; sodium fluoride, 0.0635g; 


























































   




GROUP 1:  
 
 








Effects of orchidectomy and feeding orange pulp on μCT measurements of tibial bone length in year-old Sprague-




























1Means ± SEM, (n = 8-9).   
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